Detailed answers about HIV I-BASE, including incorporation, status, business activity, and accounts information.
When was HIV I-BASE founded?
HIV I-BASE was officially incorporated on 28 March 2000 and is registered under company number 03962064. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is HIV I-BASE?
PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption). This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations.
What is the current status of HIV I-BASE?
HIV I-BASE's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does HIV I-BASE do?
HIV I-BASE operates in the following sectors: 58190 - Other publishing activities, 63990 - Other information service activities n.e.c.. These SIC codes provide insight into the company's business activities and industry focus.
What is HIV I-BASE's registered address?
The registered office address of HIV I-BASE is 2ND FLOOR REGIS HOUSE, 45 KING WILLIAM STREET, LONDON, UNITED KINGDOM, EC4R 9AN. This is the official address filed with Companies House for legal and statutory correspondence.
Is HIV I-BASE financially stable?
The most recent accounts for HIV I-BASE were made up to 31 March 2025, filed as TOTAL EXEMPTION FULL. Next accounts are due by 31 December 2026.
Does HIV I-BASE have any charges or mortgages?
HIV I-BASE has 1 registered charge, of which 0 are outstanding, 1 satisfied, and 0 part satisfied. Charges are typically registered when a company uses its assets as security for borrowing.